Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Avatarhashon Mar 01, 2018 5:22pm
356 Views
Post# 27647361

RE:RE:$14

RE:RE:$14 Its crazy when you think about it. Aphria has much more capacity and international exposure through Nuuvera. Also they have supply agreement with Quebec and other provinces. 

The other crazy thing is that Nuuvera is traded with huge discount compare to APH. Its more than 12 percent cheaper (If you buy Nuuvera right now means you bought APH at 12.3)

GR8BALLS wrote: Can’t believe Cronos is close to same market cap as Aphria.  Aphria way undervalued with room to zoom 


Bullboard Posts